Catalent, Inc. Balance Sheet | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q4 FY2025 As of Jun 30, 2025	Q4 FY2024 As of Jun 30, 2024	Q4 FY2023 As of Jun 30, 2023	Q2 FY2023 As of Dec 31, 2022	Q1 FY2023 As of Sep 30, 2022	Q4 FY2022 As of Jun 30, 2022	Q3 FY2022 As of Mar 31, 2022	Q2 FY2022 As of Dec 31, 2021	Q1 FY2022 As of Sep 30, 2021	Q4 FY2021 As of Jun 30, 2021	Q3 FY2021 As of Mar 31, 2021	Q2 FY2021 As of Dec 31, 2020	Q1 FY2021 As of Sep 30, 2020	Q4 FY2020 As of Jun 30, 2020	Q3 FY2020 As of Mar 31, 2020	Q2 FY2020 As of Dec 31, 2019
ASSETS
Current assets:
Cash and cash equivalents
Trade receivables, net
Inventories
Prepaid expenses and other
Marketable Securities
Total current assets
Property, plant, and equipment, net
Other assets:
Goodwill
Other intangibles, net
Deferred income taxes
Non-current deferred tax asset
Deferred Income Tax Assets, Net
Other Assets, Noncurrent

Total assets
Liabilities and shareholder's equity
Current Liabilities:
Debt, Current
Accounts payable
Other accrued liabilities
Total current liabilities
Long-term obligations, less current portion
Pension liability
Non-current deferred tax liability
Deferred Income Tax Liabilities, Net
Deferred Income Taxes
Other liabilities
Commitment and contingencies (see Note 14)
Total liabilities
Temporary Equity, Carrying Amount, Attributable to Parent
Common Stock, Par or Stated Value Per Share
Common Stock, Shares Authorized
Common Stock, Value, Outstanding
Preferred Stock, Value, Outstanding
Additional paid in capital
Accumulated deficit
Accumulated other comprehensive income/(loss)
Total shareholders' equity
Total liabilities, redeemable preferred stock, and shareholders’ equity

Common stock, shares issued (shares)

Comments